Westfield Capital Management Co Lp
Source: SEC Form 13F · as of Mar 2026Westfield Capital Management Co Lp holds 14 biotech & pharma companies tracked by BioSniper, totaling $1.17B in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$1.17B
BioSniper AIPage evidence connected
Prepared research question
What matters most for INSMED Inc (INSM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INSMINSMED Inc | 1,468,459 | $240.1M |
| PCVXVaxcyte, Inc. | 3,646,138 | $211.9M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 1,929,123 | $167.8M |
| RVMDREVOLUTION MEDICINES, INC. | 1,556,578 | $151.4M |
| ABVXAbivax SA | 1,322,938 | $147.3M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 245,539 | $81.2M |
| ADPTAdaptive Biotechnologies Corp | 5,436,718 | $75.5M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 2,202,913 | $70.5M |
| ORKAOruka Therapeutics, Inc. | 313,130 | $15.4M |
| GILDGILEAD SCIENCES, INC. | 26,690 | $3.7M |
| IONSIONIS PHARMACEUTICALS INC | 3,502 | $263K |
| SRRKScholar Rock Holding Corp | 5,182 | $255K |
| AVTXAvalo Therapeutics, Inc. | 15,639 | $233K |
| IMVTImmunovant, Inc. | 8,581 | $213K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.